Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Experts from AIIMS Delhi emphasised obesity’s harmful health effects and the need for preventive actions, supporting Prime ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

In nine out of ten patients with type 2 diabetes, severe obesity, known as adiposity, leads to diabetes. Type 2 diabetes is ...

Spices alone cannot directly lead to weight loss, but some have properties that may help support your weight management plan.

"The increasing prevalence of cardiovascular conditions in younger people has many factors. Key contributors include obesity, ...

President Prabowo Subianto’s universal free meals programme is well-intentioned, but it would be more effective if done in ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

"We know from the Cornell Food Lab, if you have a toaster on your counter, you are going to weigh about six pounds more than ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...